Diagnostic significance of NT-proBNP estimation in patients with acute dyspnea

Journal of the College of Physicians and Surgeons Pakistan

Volumn 21, Issue 10, 2011, Pages 584-588

  Shaikh, Kaleemullah ^a   Ahmad, Mansoor ^a  

^a CIVIL HOSPITAL   (Pakistan)

Author keywords

Acute dyspnea; Heart failure; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DYSPNEA; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

EID: 81255179262     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol 1999; 83:1A-38A.
2. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Marrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351:9-13.
3. Rodeheffer RJ, Tanaka I, Imada T, Hollister AS, Robertson D, Inagami T. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. J Am Coll Cardiol 1986; 8:18-26.
4. Redfield MM, Aarhus LL, Wright RS, Burnett Jr JC. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation 1993; 87:2016-22.
5. Lainchbury JG, Espiner EA, Nicholls MG. Cardiac hormones: diagnostic and therapeutical potential. N Z Med J 1997; 110:219-21.
6. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-30.
7. Kelly R, Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure? Ann Clin Biochem 2001; 38:94-102.
8. Wijbenga JAM, Balk AH, Boosma F, Man in't Veld AJ, Hall C. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure. Eur Heart J 1999; 20:1424-8.
9. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 1994; 343:440-4.
10. Maeda K, Takayoshi T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135:825-32.
11. Nielsen LS, Svanegaard J, Klitgaard NA, Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Failure 2004; 6:63-70.
12. Januzzi JL, van Rimmenade R, Lainchbury J. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. The International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27:330-7. Epub 2005 Nov 17.
13. Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal probrain natriuretic peptide concentrations in a large sample of the general population. Heart 2004; 90:297-303.
14. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22:1527-60. Erratum in: Eur Heart J 2001; 22:2217-8.
15. McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the breathing not properly multinational study. Am J Kidney Dis 2003; 41:571-9.
16. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro-brain natriuretic peptide in a large sample of the general population. Heart 2003; 89:745-51.
17. Arbab-Zadeh A, Dijk E, Prasad A, Fu Q, Torres P, Zhang R, et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004; 110:1799-1805. Epub 2004 Sep 13.
18. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal pro-BNP Investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95:948-54.
19. Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 2003; 42:1909-16.